Carson Wealth (CWM LLC)’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$284K Buy
2,550
+2,538
+21,150% +$300K ﹤0.01% 2420
2025
Q4
$2K Buy
+12
New +$1.31K ﹤0.01% 5045

Other funds holding ABVX

Carson Wealth (CWM LLC)'s ABVX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Abivax (ABVX) stake by 21,150% in Q1 2026, buying an estimated $300K and bringing the position to 2,550 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #2420.

Carson Wealth (CWM LLC) first reported a position in ABVX in Q4 2025 and has held it in 2 quarters since. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 2,550 shares of Abivax worth $284K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 2,538 Abivax shares in Q1 2026, an estimated $300K.
  • Abivax made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2420 holding.
  • Carson Wealth (CWM LLC) first reported a position in Abivax in Q4 2025 and has held it in 2 quarters since.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.